{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:17:42Z","timestamp":1786997862186,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vaccine.2023.04.039","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T17:29:30Z","timestamp":1682702970000},"page":"3413-3421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A thermostable tetanus\/diphtheria (Td) vaccine in the StablevaX\u2122 pre-filled delivery system"],"prefix":"10.1016","volume":"41","author":[{"given":"Juana","family":"de la Torre Arrieta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Brice\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Garcia","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4773-4995","authenticated-orcid":false,"given":"Bruce","family":"Roser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"#cr-split#-10.1016\/j.vaccine.2023.04.039_b0005.1","unstructured":"WHO 2019 NCoV UCC Systems Pfizer BioNTech Vaccine 2022.1 Eng | PDF"},{"key":"#cr-split#-10.1016\/j.vaccine.2023.04.039_b0005.2","unstructured":"n.d. https:\/\/es.scribd.com\/document\/559688399\/WHO-2019-NCoV-UCC-Systems-Pfizer-BioNTech-Vaccine-2022-1-Eng [accessed August 31, 2022]."},{"key":"10.1016\/j.vaccine.2023.04.039_b0010","unstructured":"Monitoring vaccine wastage at country level Guidelines for programme managers Immunization, Vaccines and Biologicals; 2005. https:\/\/apps.who.int\/iris\/handle\/10665\/68463 [accessed September 8, 2022]."},{"key":"10.1016\/j.vaccine.2023.04.039_b0015","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1016\/j.vaccine.2020.06.014","article-title":"A vaccine cold chain temperature monitoring study in the United Mexican States","volume":"38","author":"Falc\u00f3n","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.039_b0020","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1016\/j.vaccine.2011.05.070","article-title":"Vaccine stabilization: Research, commercialization, and potential impact","volume":"29","author":"Kristensen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.039_b0025","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1016\/j.vaccine.2007.02.052","article-title":"Freezing temperatures in the vaccine cold chain: A systematic literature review","volume":"25","author":"Matthias","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.039_b0030","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1586\/erv.12.101","article-title":"Spray drying and vaccine stabilization","volume":"11","author":"McAdams","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.04.039_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121115","article-title":"Hughes, Innovative Drying Technologies for Biopharmaceuticals","volume":"609","author":"Sharma","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2023.04.039_b0040","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1080\/21645515.2017.1356952","article-title":"Developments in the formulation and delivery of spray dried vaccines","volume":"13","author":"Kanojia","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.04.039_b0045","unstructured":"Roser Bruce, Injections, US10821210B2; n.d. https:\/\/worldwide.espacenet.com\/patent\/search\/family\/045876206\/publication\/US10821210B2?q=US10821210B2."},{"key":"10.1016\/j.vaccine.2023.04.039_b0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0378-5173(99)00163-5","article-title":"Protection of the enzyme L-asparaginase during lyophilisation-a molecular modelling approach to predict required level of lyoprotectant","volume":"187","author":"Ward","year":"1999","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.vaccine.2023.04.039_b0055","unstructured":"Roser Bruce, Garcia de Castro Arcadio, WO1999047174A1 Amorphous Glasses for Stabilizing Sensitive products; n.d. https:\/\/worldwide.espacenet.com\/patent\/search\/family\/026313295\/publication\/WO9947174A1?q=WO9947174A1."},{"key":"10.1016\/j.vaccine.2023.04.039_b0060","unstructured":"Roser Bruce, Colaco Camilo, WO9118091A1 Stabilisation Of Biological Macromolecular Substances And Other Organic Compounds; n.d. https:\/\/worldwide.espacenet.com\/patent\/search\/family\/010675945\/publication\/WO9118091A1?q=WO9118091 [accessed September 7, 2022]."},{"key":"10.1016\/j.vaccine.2023.04.039_b0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/pro.3","article-title":"Effect of trehalose on protein structure","volume":"18","author":"Jain","year":"2009","journal-title":"Protein Sci"},{"key":"10.1016\/j.vaccine.2023.04.039_b0070","unstructured":"Roser Bruce, GB2187191A. Protection of proteins and the like; n.d. https:\/\/worldwide.espacenet.com\/patent\/search\/family\/027449677\/publication\/GB2187191A?q=GB2187191A."},{"key":"10.1016\/j.vaccine.2023.04.039_b0075","unstructured":"Roser Bruce, Colaco Camilo, Kampinga Jaap, Smith Christopher. US6890512B2 Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby; n.d. https:\/\/worldwide.espacenet.com\/patent\/search\/family\/022958303\/publication\/US6890512B2?q=US6890512B2 [accessed September 7, 2022]."},{"key":"10.1016\/j.vaccine.2023.04.039_b0080","first-page":"193","article-title":"Stabilisation of vaccines using trehalose (Q-T4) technology","volume":"87","author":"Gribbon","year":"1996","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2023.04.039_b0085","article-title":"US5149653","author":"Roser","year":"1992","journal-title":"Preservation of Viruses"},{"key":"10.1016\/j.vaccine.2023.04.039_b0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2217\/17460913.1.1.21","article-title":"Stable Liquid Drugs and Vaccines for the 21st Century","volume":"1","author":"Bruce","year":"2006","journal-title":"Future Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2023.04.039_b0095","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1021\/j100345a006","article-title":"Phase relations and vitrification in saccharide-water solutions and the trehalose anomaly","volume":"93","author":"Green","year":"1989","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.vaccine.2023.04.039_b0100","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3390\/molecules13081773","article-title":"Sachinvala and Mitsuhiro Shibata Trehalose and Trehalose-based Polymers for Environmentally Benign, Biocompatible and Bioactive Materials","volume":"13","author":"Teramoto*","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.vaccine.2023.04.039_b0105","first-page":"191","article-title":"Design of Freeze-Drying Processes for Pharmaceuticals","volume":"21","author":"Tang","year":"2004","journal-title":"Practical Advice; Pharmaceutical Research"},{"key":"10.1016\/j.vaccine.2023.04.039_b0110","unstructured":"Bul Bio-National Center of Infectious and Parasitic Diseases Ltd., tetadif; n.d. https:\/\/extranet.who.int\/pqweb\/content\/tetadif [accessed September 7, 2022]."},{"key":"10.1016\/j.vaccine.2023.04.039_b0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12249-018-1254-2","article-title":"Stability of Vaccines","volume":"20","author":"Dumpa","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.vaccine.2023.04.039_b0120","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2023.04.039_b0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.colsurfa.2008.07.031","article-title":"Protection of aluminum hydroxide during lyophilisation as an adjuvant for freeze-dried vaccines","volume":"330","author":"Wolff","year":"2008","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.vaccine.2023.04.039_b0130","doi-asserted-by":"crossref","first-page":"8732","DOI":"10.1016\/j.vaccine.2007.10.026","article-title":"Jacobsen, Determination of aluminium content in aluminium hydroxide formulation by FT-NIR transmittance spectroscopy","volume":"25","author":"Lai","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.039_b0135","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jim.2009.09.002","article-title":"Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines","volume":"350","author":"Coombes","year":"2009","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2023.04.039_b0140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.biologicals.2012.07.011","article-title":"In vitro antigen ELISA for quality control of tetanus vaccines","volume":"40","author":"Coombes","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2023.04.039_b0145","unstructured":"WHO guidelines on stability testing of active pharmaceutical ingredients and finished pharmaceutical products; n.d. https:\/\/www.who.int\/publications\/m\/item\/who-guidelines-on-stability-testing-of-active-pharmaceutical-ingredients-and-finished-pharmaceutical-products [accessed October 7, 2022]."},{"key":"10.1016\/j.vaccine.2023.04.039_b0155","unstructured":"Lloyd J. Technologies for vaccine delivery in the 21st century. World Health Organization Geneva 2000 in collaboration with DEPARTMENT OF VACCINES AND BIOLOGICALS; 2000. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/66569\/WHO_VB_00.35-eng.pdf?sequence=1."},{"key":"10.1016\/j.vaccine.2023.04.039_b0160","unstructured":"Heat-stable vaccines urgently needed to reach the one in five children missed by immunisation worldwide | MSF; n.d. https:\/\/www.msf.org\/heat-stable-vaccines-urgently-needed-reach-one-five-children-missed-immunisation-worldwide."},{"key":"10.1016\/j.vaccine.2023.04.039_b0165","unstructured":"https:\/\/cepi.net\/get_involved\/cfps\/?learn-more-7106=38."},{"key":"10.1016\/j.vaccine.2023.04.039_b0170","doi-asserted-by":"crossref","unstructured":"Alcock M.G., Cottingham C.S., Rollier J., de Furze S.D., Costa M., Hanlon A.J., et al. Hill, Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass. Sci Transl Med . 2010 2,19ra12. doi:10.1126\/scitranslmed.3000490.","DOI":"10.1126\/scitranslmed.3000490"},{"key":"10.1016\/j.vaccine.2023.04.039_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007152","article-title":"Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin","volume":"4","author":"Quan","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.04.039_b0180","unstructured":"Primary Packaging | Vetter; n.d. https:\/\/www.vetter-pharma.com\/en\/services\/packaging-and-assembly\/primary-packaging\/ [accessed September 1, 2022]."},{"key":"10.1016\/j.vaccine.2023.04.039_b0185","doi-asserted-by":"crossref","DOI":"10.2174\/0929867324666170526124053","article-title":"Microneedle Patches as Drug and Vaccine Delivery Platform","volume":"24","author":"Li","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.vaccine.2023.04.039_b0190","unstructured":"HydRIS (Hypodermic Rehydration Injection System); n.d. https:\/\/www.novalabs.co.uk\/stabilisation-technologies."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:26:22Z","timestamp":1759404382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23004310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":38,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0264410X23004310"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.039","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.02.16.526924","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A thermostable tetanus\/diphtheria (Td) vaccine in the StablevaX\u2122 pre-filled delivery system","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Stablepharma Ltd, 4 Queen St, Bath, BA1 1HE, UK. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}